PGRMC1 and ovarian carcinoma: Moreover, the latest research has found that PGRMC1 induces autophagy through directly binding with light chain 3 beta 2 (LC3B2) [26], and hyperoside can sensitize ovarian cancer cells to cisplatin by activating PGRMC1-dependent autophagy [27].